Type 2 diabetes with other specified/multiple/unspecified complications

E4_DM2NASCOMP

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 E11.6, E11.6+M14.2, E11.6+M14.6, E11.7, E11.8
Hospital discharge: ICD-9 2507A|2508A
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 E11.6, E11.6+M14.2, E11.6+M14.6, E11.7, E11.8
Cause of death: ICD-9 2507A|2508A
Cause of death: ICD-8 $!$
KELA reimbursements: KELA codes ANY
KELA reimbursements: ICD-10 E11

164988

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

37072

diagram downward connector

Check minimum number of events None

37072

diagram downward connector

Include endpoints None

37072

diagram downward connector
E4_DM2NASCOMP

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 35857 15895 19962
Unadjusted prevalence (%) 11.62 9.16 14.78
Mean age at first event (years) 61.61 61.17 61.96

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.36 [2.08, 2.68] 1.5e-39 4353
15 years 0.01 1.29 [1.14, 1.45] 4.1e-5 1897
5 years 0.00 2.62 [2.36, 2.91] 1.1e-72 1241
1 year 0.00 8.25 [7.25, 9.39] <1e-100 762

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: E4_DM2NASCOMP – Type 2 diabetes with other specified/multiple/unspecified complications
GWS hits: 94

Survival analyses between endpoints

Plot

before Type 2 diabetes with other specified/multiple/unspecified complications
after Type 2 diabetes with other specified/multiple/unspecified complications

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Type 2 diabetes with other specified/multiple/unspecified complications